Imunon, Inc. — Director's Dealing 2025

Feb 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imunon, Inc. (IMNN)
CIK: 0000749647
Period of Report: 2025-02-18

Reporting Person: Faller Douglas Vincent (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-18	Stock Option (Right to Buy)	$0.862	A	100000	Acquired	2035-02-18	Common Stock (100000)	Direct

Footnotes

F1: Represents the closing price of Imunon, Inc. Common Stock on the date of the grant

F2: The options shall vest and become exercisable as to 1/4 on the one year anniversary of the grant date and each remaining 1/4 on the second, third and fourth year anniversary of the grant date, subject to the grantee's continued service as an employee through each applicable vesting date.